Is MEDICINOVA INC (MNOV) Halal?
Shariah Screening — 5 Standards
Based on financial data from December 2024
| Standard | Debt Ratio | Cash Ratio | Receivables | Income | Status |
|---|---|---|---|---|---|
| AAOIFI | 0.3% / 30% | 60.3% / 30% | 0.0% / 30% | N/A | ✗ NOT HALAL |
| DJIM | 0.3% / 33% | 60.3% / 33% | 0.0% / 33% | N/A | ✗ NOT HALAL |
| MSCI | 0.3% / 33% | 72.2% / 33% | 0.0% / 33% | N/A | ✗ NOT HALAL |
| S&P | 0.3% / 33% | 60.3% / 33% | 0.0% / 33% | N/A | ✗ NOT HALAL |
| FTSE | 0.3% / 33% | 72.2% / 33% | 0.0% / 50% | N/A | ✗ NOT HALAL |
Financial Highlights
Profitability
| Gross Margin | 7.6% | |
| Operating Margin | -2038.0% | |
| Net Margin | 0.0% | |
| Return on Equity (ROE) | -25.5% | |
| Return on Assets (ROA) | -16.4% |
Cash Flow & Balance Sheet
| Operating Cash Flow | -$11M |
| Free Cash Flow | -$11M |
| Total Debt | $193,769 |
| Debt-to-Equity | 0.5 |
| Current Ratio | 8.2 |
| Total Assets | $56M |
Price & Trading
| Last Close | $1.42 |
| 50-Day MA | $1.54 |
| 200-Day MA | $1.39 |
| Avg Volume | 81K |
| Beta | 0.6 |
|
52-Week Range
$1.13
| |
About MEDICINOVA INC (MNOV)
MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. It develops MN-166 (ibudilast), an oral anti-inflammatory and neuroprotective agent in Phase 2 clinical trial for treating neurological and other disorders, such as progressive multiple sclerosis, amyotrophic lateral sclerosis, chemotherapy-induced peripheral neuropathy, degenerative cervical myelopathy, and glioblastoma, as well as prevention of acute respiratory distress syndrome. The company is also developing MN-001 (tipelukast), an orally bioavailable small molecule compound in Phase 2 clinical trial to treat fibrotic and other metabolic disorders, including nonalcoholic fatty liver disease and hypertriglycedemia. MediciNova, Inc. was incorporated in 2000 and is headquartered in La Jolla, California.
Related Halal Stocks in Healthcare
Frequently Asked Questions
Is MEDICINOVA INC (MNOV) halal to invest in?
Based on our screening using AAOIFI Standard 21 (the strictest methodology), MEDICINOVA INC is Not Halal. The company fails one or more screening criteria. We screen against all 5 major standards: AAOIFI, DJIM, MSCI, S&P, and FTSE.
What is MEDICINOVA INC's debt ratio?
MEDICINOVA INC's debt ratio is 0.3% under the AAOIFI standard (which uses market capitalization as the denominator). The AAOIFI threshold is 30%. Under MSCI and FTSE (which use total assets as the denominator), the debt ratio is 0.3%.
What are MEDICINOVA INC's key financial metrics?
MEDICINOVA INC has a market capitalization of $68M. Return on equity stands at -25.5%.
How often is the screening data updated?
Our screening data is updated regularly using the latest available financial statements and market data. Stock prices and market caps are refreshed frequently, while financial statements are updated quarterly when companies report earnings.
Disclaimer: HalalStockGuide.com provides Shariah compliance screening for educational and informational purposes only. This is not a fatwa, financial advice, or a recommendation to buy or sell any security. Screening results are based on publicly available financial data and established methodologies. Always consult a qualified Islamic scholar and a licensed financial advisor before making investment decisions.